These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Long-term follow-up of full macular translocation for choroidal neovascularization. Yamada Y, Miyamura N, Suzuma K, Kitaoka T. Am J Ophthalmol; 2010 Mar; 149(3):453-7.e1. PubMed ID: 20035923 [Abstract] [Full Text] [Related]
3. Long-Term Results of Full Macular Translocation for Choroidal Neovascularization in Age-Related Macular Degeneration. van Romunde SH, Polito A, Bertazzi L, Guerriero M, Pertile G. Ophthalmology; 2015 Jul; 122(7):1366-74. PubMed ID: 25881514 [Abstract] [Full Text] [Related]
4. Visual function 5 years or more after macular translocation surgery for myopic choroidal neovascularisation and age-related macular degeneration. Takeuchi K, Kachi S, Iwata E, Ishikawa K, Terasaki H. Eye (Lond); 2012 Jan; 26(1):51-60. PubMed ID: 22173070 [Abstract] [Full Text] [Related]
5. Change in visual function after macular translocation with 360 degrees retinectomy for neovascular age-related macular degeneration. Mruthyunjaya P, Stinnett SS, Toth CA. Ophthalmology; 2004 Sep; 111(9):1715-24. PubMed ID: 15350328 [Abstract] [Full Text] [Related]
6. Photodynamic therapy vs limited macular translocation in the management of subfoveal choroidal neovascularization in pathologic myopia: a two-year study. Glacet-Bernard A, Benyelles N, Dumas S, Haddad WM, Voigt M, Razavi S, Roquet W, Coscas G, Soubrane G. Am J Ophthalmol; 2007 Jan; 143(1):68-76. PubMed ID: 17188042 [Abstract] [Full Text] [Related]
7. Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results. Ikuno Y, Sayanagi K, Soga K, Sawa M, Tsujikawa M, Gomi F, Tano Y. Am J Ophthalmol; 2009 Jan; 147(1):94-100.e1. PubMed ID: 18774550 [Abstract] [Full Text] [Related]
12. Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy. Hayashi K, Ohno-Matsui K, Teramukai S, Shimada N, Moriyama M, Hayashi W, Yoshida T, Tokoro T, Mochizuki M. Am J Ophthalmol; 2009 Sep; 148(3):396-408. PubMed ID: 19427991 [Abstract] [Full Text] [Related]
14. Surgical treatment of subfoveal neovascularization in myopia: macular translocation vs surgical removal. Hamelin N, Glacet-Bernard A, Brindeau C, Mimoun G, Coscas G, Soubrane G. Am J Ophthalmol; 2002 Apr; 133(4):530-6. PubMed ID: 11931787 [Abstract] [Full Text] [Related]
15. Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia. Sakaguchi H, Ikuno Y, Gomi F, Kamei M, Sawa M, Tsujikawa M, Oshima Y, Kusaka S, Tano Y. Br J Ophthalmol; 2007 Feb; 91(2):161-5. PubMed ID: 16914470 [Abstract] [Full Text] [Related]
16. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study. Chan WM, Lai TY, Liu DT, Lam DS. Ophthalmology; 2007 Dec; 114(12):2190-6. PubMed ID: 17599414 [Abstract] [Full Text] [Related]